Diebold Nixdorf, Incorporated DBD
62.72
0.25
0.40%
as of 25 Sep
- Market cap
- $2.1B
- P/E
- 20.2×
Follow DBD
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 10.68% | 10.70% | 9.26% | 4.62% |
+8 more TTM periods Free account |
|
| 2.97% | 2.89% | 2.56% | 1.33% | ||
ROIC |
9.40% | 9.62% | 9.30% | 7.10% | |
Return on Tangible Assets |
16.66% | 15.66% | 13.49% | 6.97% | |
Average Days of Receivables |
61.48 | 56.50 | 64.14 | 57.37 | |
Free Cash Flow per Share |
6.16 | 7.23 | 6.49 | 6.29 | |
Free Cash Flow |
212.00 | 253.60 | 239.00 | 229.50 | |
Capital Expenditures |
(61.00) | (63.10) | (61.70) | (49.90) | |
Piotroski F-Score |
6.00 | 7.00 | 7.00 | 7.00 | |
| Other line items | |||||
Cash ROIC |
12.40% | 13.54% | 12.23% | 12.01% | |
Accounts Receivable Turnover |
6.19 | 6.43 | 6.05 | 5.93 | |
Accounts Payable Turnover |
6.17 | 6.19 | 6.38 | 5.90 | |
Inventory Turnover |
4.95 | 5.22 | 5.42 | 4.48 | |
Average Days of Payables |
63.83 | 61.07 | 55.32 | 60.68 | |
Days of Inventory on Hand |
75.14 | 69.99 | 66.85 | 78.81 | |
Tax Rate |
(0.28) | (0.22) | (0.19) | (0.26) | |
Research and Development Expense of Revenue |
2.17% | 2.23% | 2.28% | 2.42% | |
Selling, General and Administrative Expense of Revenue |
16.68% | 16.54% | 16.62% | 16.86% | |
Share Based Compensation of Revenue |
0.34% | 0.32% | 0.32% | 0.31% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
2.46 | 2.94 | 3.18 | 5.52 | |
Depreciation/Fixed assets |
0.43 | 0.45 | 0.47 | 0.52 | |
Capex/Depreciation |
(0.46) | (0.48) | (0.46) | (0.36) | |
Revenue per Share |
112.56 | 109.87 | 103.42 | 101.11 | |
Operating CF per Share |
7.94 | 9.02 | 8.17 | 7.65 | |
Capex per Share |
(1.77) | (1.80) | (1.68) | (1.37) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.01 | |
Net Profit Margin |
2.87% | 2.80% | 2.49% | 1.37% |
Columns are period end dates